Drug intelligence / Profile preview

Ku Qin Formula

Development stage
Unknown
Lead developer
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration
Oral
01

Overview

Ku Qin Formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Yueyang Hospital of Integrative Medicine at the Shanghai University of Traditional Chinese Medicine. It is primarily investigated for the treatment of prurigo nodularis, a chronic inflammatory skin condition characterized by symmetric, intensely pruritic nodules. The formula's name is derived from its two primary constituent herbs: Ku Shen (Sophora flavescens) and Huang Qin (Scutellaria baicalensis), which are traditionally used in TCM to clear heat and dry dampness. In clinical research, the formula is being evaluated as a sequential or adjunctive therapy alongside the IL-4/IL-13 inhibitor dupilumab. The study aims to determine if the addition of Ku Qin Formula can accelerate itch relief, improve skin lesion clearance, and potentially allow for a shorter duration of dupilumab treatment while maintaining long-term disease control and safety.

Other names
Ku Qin FormulaKuqin Formula

Beyond the preview

Go deeper on Ku Qin Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ku Qin Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call